- Report
- May 2024
- 136 Pages
Global
From €6230EUR$6,499USD£5,206GBP
- Report
- June 2024
- 200 Pages
Global
From €7621EUR$7,950USD£6,368GBP
- Report
- July 2023
- 150 Pages
Global
From €5704EUR$5,950USD£4,766GBP
- Report
- January 2022
- 60 Pages
Global
From €3787EUR$3,950USD£3,164GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1917EUR$2,000USD£1,602GBP
- Report
- October 2023
- 171 Pages
Global
From €4314EUR$4,500USD£3,605GBP
The Dupuytren Contracture Drug market is a subset of the larger Musculouskeletal Disorders Drugs market. It is focused on treatments for Dupuytren Contracture, a condition that affects the connective tissue in the palm of the hand and can cause the fingers to curl inwards. Treatment options include surgery, collagenase injections, and radiation therapy.
Collagenase injections are the most common treatment for Dupuytren Contracture, and the market is dominated by a few major players. Companies in the market include Auxilium Pharmaceuticals, Endo Pharmaceuticals, and BioSpecifics Technologies. Other companies, such as Ferring Pharmaceuticals, have recently entered the market with their own collagenase injection products. Show Less Read more